$CFTR-PA Balance Sheet | Understand Stock

$CFTR-PA

$CFTR-PA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Investment in real estate, net of accumulated depreciation of $121,088,400 and $113,331,033, respectively
Cash
Restricted cash
Investments in real estate-related assets
Investment in debt securities, at fair value
Investment in real estate, held for sale
Investment in infrastructure fund, at fair value
Intangible assets, net of accumulated amortization of $52,853,469 and $53,669,340 respectively
Operating lease right-of-use asset
Derivative assets, at fair value
Prepaid expenses and other assets
Deferred rent receivable
Due from related party
Stock subscriptions receivable
Accrued preferred return receivable
Accrued income from mezzanine loan investment
Total assets

Liabilities and Equity
Liabilities
Loans payable, net of deferred financing costs of $4,614,469 and $5,156,704, respectively
Intangible liabilities, net of accumulated amortization of $8,720,391 and 9,862,831, respectively
Operating lease liability
Distributions payable
Restricted reserves
Due to related parties
Deferred revenue
Accrued interest payable
Accounts payable and accrued expenses
Derivative liabilities, at fair value
Total liabilities

Commitments and contingencies (Note 13)
Stockholders' equity
9.50% Series A cumulative redeemable perpetual preferred stock, $0.01 par value per share, 50,000,000 shares authorized, and 800,000 and 0 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
9.50% Series A Cumulative Redeemable Preferred Stock
Total 9.50% Series A cumulative redeemable perpetual preferred stock, $0.01 par value per share, 50,000,000 shares authorized, and 800,000 and 0 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Common stock
Class AX
Class TX
Class IX
Class T
Class S
Class D
Class I
Additional paid-in capital
Retained earnings/accumulated deficit and cumulative distributions
Accumulated other comprehensive income
Total controlling interest
Non-controlling interests in subsidiaries
Non-controlling interests attributable to consolidated subsidiaries
Non-controlling interests attributable to CFIT OP
Stockholders' equity
Class AX
Class TX
Class IX
Class T
Class S
Class D
Class I
Total stockholders' equity

Total liabilities and stockholders' equity

Comments